Modest daily walking linked to slower Alzheimer's progression, with benefits plateauing around 5,000–7,500 steps per day.
Investor Watchlist highlights key small-cap stocks facing growth challenges, with some firms showing improved profitability or cash generation, while others face risks like weak revenue, high costs, and cash burn.
FDA drug regulator resigns amid bribery and defamation allegations, denies wrongdoing and claims retaliation for criticizing agency officials.
Modest daily walking linked to slower Alzheimer's progression, with benefits plateauing around 5,000–7,500 steps per day.
Investor Watchlist highlights key small-cap stocks facing growth challenges, with some firms showing improved profitability or cash generation, while others face risks like weak revenue, high costs, and cash burn.
FDA drug regulator resigns amid bribery and defamation allegations, denies wrongdoing and claims retaliation for criticizing agency officials.